Doxycycline safety during pregnancy: a large population-based cohort of pregnancies
First-trimester doxycycline use was not associated with increased major congenital malformation risk, and most late-pregnancy outcomes were unaffected. These findings support the relative safety of doxycycline when clinically indicated during pregnancy.
Authors
- Tal Michael (ORCID: https://orcid.org/0000-0002-0328-055X)
- Itamar Ben Shitrit (ORCID: https://orcid.org/0009-0002-7093-8953)
- Sharon Daniel (ORCID: https://orcid.org/0000-0003-1820-9278)
- Eitan Lunenfeld (ORCID: https://orcid.org/0000-0003-2260-9530)
- Amalia Levy (ORCID: https://orcid.org/0000-0002-2355-8854)
- Gali Pariente (ORCID: https://orcid.org/0000-0001-6484-3769)
- Daphna Idan
- Ariel Avraham Hassidim
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Schneider Children's Medical Center (IL)
- Ariel University (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- Infection
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1007/s15010-025-02622-9
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ben-Gurion University of the Negev